THE INNOVATIVE MEDICINES INITIATIVE
The Innovative Medicines Initiative (IMI) is Europe's largest public-private initiative aiming to speed up the development of better and safer medicines for patients.
IMI supports collaborative research projects and builds networks of industrial and academic experts in order to boost pharmaceutical innovation in Europe.
IMI is a joint undertaking between the European Union and the pharmaceutical industry association EFPIA.
Sign up for the IMI 2 - Call 5 webinars
Webinars on all IMI2 - Call 5 topics plus IMI's rules and procedures will be held from 1 to 14 July inclusive.
The full schedule and registration information can be found on the webinar page.
- 01/07/2015 : RT @AD_PREVENT: On way to #RCPsychIC to present @IMI_EPAD and @AD_PREVENT in #Birmingham #brainhealth ☀️☀️
- 01/07/2015 : RT @DRIVE_AB: AM: Interested in contributing to innovative, global solutions to #saveabx ? Register to be a stakeholder today! http://t.co/…
- 01/07/2015 : RT @EFA_Patients: Getting closer to solve the #severeasthma puzzle - Our views on the @UBIOPRED Results Symposium: http://t.co/qzU2vHhAJe @…